Equate Lubricant Eye Ointment Recalled for Lack of Sterility Assurance
Equate Lubricant Eye Ointment, distributed nationwide by Walmart, is being recalled because the manufacturer cannot assure the product's sterility. The recall affects 315,842 units across multiple lots.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II recall for lack of sterility assurance in an ophthalmic medication. No illnesses or hospitalizations reported, placing this at High severity as a risk-of-harm product where injury has not yet been reported.
Plain-English summary
Equate Lubricant Eye Ointment is being recalled by the FDA. The product is supplied in 3.5-gram tubes containing Mineral Oil 42.5% and White Petrolatum 57.3%, manufactured by Brassica Pharma Pvt Ltd and distributed nationwide by Walmart Inc.
The recall is due to a lack of assurance of sterility. The FDA has classified this as a Class II recall, indicating that the manufacturer cannot adequately ensure the product meets sterility standards required for ophthalmic medications.
The recall affects 315,842 units distributed nationwide in the United States. The affected lots and expiration dates are: Lot A2E01 (Exp. Apr 2024), Lot A2L05 (Exp. Nov 2024), Lot A3B01 (Exp. Jan 2025), and Lot A3C01 (Exp. Feb 2025). The product is identified by NDC 79903-026-35 and UPC 681131395298.
Consumers who have purchased this product may contact their healthcare provider for guidance. Retailers should remove the product from shelves.
The recalled product
- Product
- Equate Lubricant Eye Ointment (Mineral Oil 42.5%, White Petrolatum 57.3%), Packaged in 3.5 gram tubes, Distributed by Walmart Inc., Bentonville, AR 72716, NDC 79903-026-35, UPC 681131395298
- Manufacturer
- Brassica Pharma Pvt Ltd
- Category
- Drug — Ophthalmic
- Hazard
- lack-of-sterility
- contamination-risk
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (8)
- Lot #: A2E01
- Exp. Date Apr-24
- A2L05
- Exp. Date Nov-24
- A3B01
- Exp. Date Jan-25
- A3C01
- Exp. Date Feb-25
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27